[Libourne, France, April 14, 2026] – Fermentalg unveils OMEGA ΩRIGINS EPA/DHA, a new generation of omega-3-rich algal oils. The result of several years of R&D, this innovation is based on a patented fermentation process that achieves EPA and DHA concentrations unprecedented on the market — naturally, without any concentration step. Designed to meet growing expectations around longevity, performance, and overall well-being, the OMEGA ΩRIGINS EPA/DHA range targets the dietary supplements, functional food & beverage, and pet nutrition markets, with grades specifically developed for each application. This breakthrough opens up new opportunities for brands seeking powerful, sustainable, and differentiated ingredients.
A true innovation: record-breaking EPA and DHA levels, achieved naturally
At the heart of the OMEGA ΩRIGINS™ range, the 400/200 ratio (40% EPA + 20% DHA) represents a world first: until now, no algal oil has reached such a high EPA content without undergoing a concentration process. This achievement is made possible by a patented fermentation process applied to Fermentalg’s proprietary Schizochytrium sp. FCC-3204 strain.
With total omega-3 content reaching up to 60%, this oil stands as the most potent algal alternative to fish oil on the market, while addressing growing consumer demand for sustainability and natural solutions.
“Our R&D teams have been working for several years to develop an algal oil combining EPA and DHA to expand our range of functional lipids. We are particularly proud to introduce a truly unique innovation on the market, especially with the 400/200 EPA/DHA ratio, our flagship product. This launch reflects outstanding teamwork and demonstrates our commitment to supporting our customers with innovative solutions aligned with today’s and tomorrow’s health and sustainability challenges” said Alexia RENARD, Product Marketing Manager at Fermentalg.
To meet diverse market needs, Fermentalg also offers a full range of EPA/DHA ratios: 400/200, 300/200, 150/300, and 100/500, enabling manufacturers to tailor their formulations with precision.
Produced in Europe under strict quality standards and validated by an expert sensory panel, these oils meet the requirements of the dietary supplements and functional food & beverage markets.
A solution at the heart of market trends: longevity, sports nutrition, and innovative formats
OMEGA ΩRIGINS™ directly addresses the major trends shaping the global dietary supplements market. As consumers increasingly adopt preventive approaches to ageing and personalised nutrition (particularly in sports), Fermentalg’s oils offer brands a unique opportunity to develop differentiated, high-performance, science-backed solutions.
Thanks to their EPA and DHA omega-3 content, OMEGA ΩRIGINS products enable the use of EFSA-approved health claims, particularly related to:
- Cardiovascular health (heart health, blood triglyceride levels, blood pressure),
- Cognitive function,
- Visual health.
Numerous scientific studies also highlight their potential benefits for sports performance (endurance, recovery, sleep quality), as well as muscle and joint health, mobility, and overall well-being for active and ageing populations.
Furthermore, with total omega-3 content reaching up to 60%, OMEGA ΩRIGINS oils pave the way for innovative formats: smaller, easier-to-swallow softgels, or additional room for other active ingredients in formulations. Fermentalg offers grades protected with adapted antioxidants and suitable for a wide range of applications, ensuring stability across formats such as softgels, gummies, powders, emulsions, and liquid forms.
For more information or sample requests: sales@fermentalg.com
Download the OMEGA ΩRIGINS flyer here: OMEGA ORIGINS ALGAL EPA/DHA